Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilretta in Greater Trochanteric Bursitis
NCT04182672Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 2020
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in trochanteric bursitis, sponsored by UTHealth Houston. Started Aug 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
trochanteric bursitis
Beyond the preview
Go deeper on NCT04182672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04182672.